Troutman Sanders will host in-house counsel, compliance professionals, executives and managers at a complimentary forum on current legal and policy issues facing pharmaceutical companies, from start-ups to Fortune 100 entities. This program, chaired by Troutman Sanders partners Aurora Cassirer and Joe Robinson will include presentations and panel discussions on a wide variety of topics including government investigations, state attorneys general actions, environmental regulations, antitrust considerations, generic labeling, tax inversions, the Foreign Corrupt Practices Act, product liability, securities litigation, regulatory compliance, and intellectual property issues.
Our speakers, which include representatives from several government agencies, will discuss the latest developments and tactics for dealing with the high-stakes challenges affecting the pharmaceutical industry today.
The program will be followed by a cocktail reception.
Agenda: Click here
Co-Sponsors: KPMG, International Corporate Compliance Committee for the New York State Bar Association, and the Compliance Affinity Group of Fordham Law School
CLE credits pending : 7 New York, 8.4 New Jersey.
RSVP to: bryan.emerson@troutmansanders.com